At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Two years ago, we published a list of 5 predictions about AI in the year 2030. The article sparked a lot of fascinating (and ...

For European start-ups, the past quarter has been the strongest in four years, with significant funding in the UK, Germany ...

Google will add SandboxAQ’s so-called large quantitative models to its cloud marketplace, allowing researchers to combine ...

Currently universities across Bangladesh seem to be locked in an exhausting, state-mandated ritual. Instead of refreshing the ...

Google Cloud will offer SandboxAQ’s large quantitative models for drug discovery, materials science and chip-making, alongside Gemini for Science.

Alphabet shares fell 5 percent, erasing 270 billion in value, after AI leaders Noam Shazeer joined OpenAI and John Jumper left Google DeepMind for Anthropic, spooking investors ...

Little Britain squares up to America’s big AI beasts at London Tech Week - Squabbles over social media and AI set the tone at the capital’s annual technology shindig, reports Alex Pell ...

With Google's AI models losing leaderboard places and its pace of model releases lagging, some are questioning if the ...

The rise of AI in drug development is just beginning its journey to delivering treatments to patients.